search
Back to results

Cognitive Behavioral Therapy for Health Anxiety: Internet Treatment Versus Face-to-Face Therapy (HA-NonInf)

Primary Purpose

Severe Health Anxiety, Somatic Symptom Disorder, Illness Anxiety Disorder

Status
Completed
Phase
Not Applicable
Locations
Sweden
Study Type
Interventional
Intervention
CBT, exposure and response prevention (Face-to-face)
CBT, exposure and response prevention (Internet-based)
Sponsored by
Karolinska Institutet
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Severe Health Anxiety focused on measuring Severe health anxiety, Somatic symptom disorder, Illness anxiety disorder, Cognitive behavioral therapy, Internet, Exposure

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • A primary diagnosis of severe health anxiety (somatic symptom disorder or illness anxiety disorder) according to the Diagnostic and Statistical Manual of Mental Disorders 5 (DSM-5)
  • Registered citizen of Stockholm county
  • At least 18 years old

Exclusion Criteria:

  • Other primary axis-I disorder
  • Substance abuse or addiction during the last 6 months
  • Current or previous episode of psychosis or bipolar disorder
  • Severe major depressive disorder
  • Suicide risk
  • Personality disorder making the treatment procedure very difficult
  • Non-stable psychiatric pharmacotherapy (dosage changed during the last 2 months) and the drug is likely to affect outcome measures
  • Ongoing concurrent psychological treatment for severe health anxiety
  • Having received previous high quality Cognitive Therapy or Cognitive Behavioural Therapy during the recent year
  • Ongoing serious somatic disorder, precluding CBT

Sites / Locations

  • Gustavsberg primary care clinic

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Experimental

Arm Label

Conventional CBT

Internet-delivered CBT

Arm Description

Cognitive Behavioural Therapy delivered in a conventional manner

Cognitive Behavioural Therapy delivered via the Internet

Outcomes

Primary Outcome Measures

Health Anxiety Inventory (HAI)
Change in HAI at post-treatment and follow-ups compared to baseline. Analyses will be conducted both within an intention-to-treat (ITT) framework and on a complete case basis. A non-inferiority limit of 0.3 d (effect size) will be used.

Secondary Outcome Measures

Illness Attitude Scale (IAS)
Change in IAS at post-treatment and follow-ups compared to baseline
Whiteley Index (WI)
Change in WI at post-treatment and follow-ups compared to baseline
Montgomery-Åsberg Depression Rating Scale - Self report (MADRS-S)
Change in MADRS-S at post-treatment and follow-ups compared to baseline
Beck Anxiety Inventory (BAI)
Change in BAI at post-treatment and follow-ups compared to baseline
Anxiety Sensitivity Index (ASI)
Change in ASI at post-treatment and follow-ups compared to baseline
Sheehan Disability Scale (SDS)
Change in SDS at post-treatment and follow-ups compared to baseline
Trimbos and institute of medical technology assessment cost questionnaire (TIC-P)
Change in TIC-P at post-treatment and follow-ups compared to baseline
Euroqol-5D (EQ-5D)
Change in EQ-5D at post-treatment and follow-ups compared to baseline
Insomnia Severity Index (ISI)
Change in ISI at post-treatment and follow-ups compared to baseline
Self-rated health 5 (SRH-5)
Change in SRH-5 at post-treatment and follow-ups compared to baseline
Quality of Life Inventory (QOLI)
Change in QOLI at post-treatment and follow-ups compared to baseline
Alcohol Use Disorders Identification Test (AUDIT)
Change in AUDIT at post-treatment and follow-ups compared to baseline
Client Satisfaction Questionnaire (CSQ-8)
For assessing satisfaction with treatment
Sickness Questionnaire (SQ)
Change in SQ at post-treatment and follow-ups compared to baseline
Perceived Vulnerability for Disease (PVD)
Change in PVD at post-treatment and follow-ups compared to baseline
Disgust Scale-Rev (DS-R)
Change in DS-R at post-treatment and follow-ups compared to baseline
WHO Disability Assessment Schedule (WHODAS) 2.0, 12-item version
Change in WHODAS at post-treatment and follow-ups compared to baseline

Full Information

First Posted
December 8, 2014
Last Updated
October 28, 2020
Sponsor
Karolinska Institutet
search

1. Study Identification

Unique Protocol Identification Number
NCT02314065
Brief Title
Cognitive Behavioral Therapy for Health Anxiety: Internet Treatment Versus Face-to-Face Therapy
Acronym
HA-NonInf
Official Title
Cognitive Behavioral Therapy for Health Anxiety: a Randomized Controlled Non-inferiority Trial of Internet-delivered and Face-to-Face Therapy
Study Type
Interventional

2. Study Status

Record Verification Date
October 2020
Overall Recruitment Status
Completed
Study Start Date
December 10, 2014 (Actual)
Primary Completion Date
July 23, 2018 (Actual)
Study Completion Date
July 23, 2018 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Karolinska Institutet

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Background Severe health anxiety is a highly distressing, often debilitating, psychological problem. Since the release of the Diagnostic and Statistical Manual of Mental Disorders 5 (DSM-5) its clinical manifestations are increasingly often referred to as Somatic Symptom Disorder (SSD) or Illness Anxiety Disorder (IAD). Despite often being overlooked in routine care, several treatments for severe health anxiety have shown great promise, the most well-established being Cognitive Behavioral Therapy (CBT). Traditionally, CBT - like most other psychotherapies - has typically been delivered face-to-face. That is, the patient physically meeting with the therapist once a week for the whole of the treatment. Internet-delivered CBT does not rest on this requirement, but has nevertheless been shown to be efficacious for severe health anxiety (see for example NCT01673035). Aim of the study The present study aims to compare the effects of Internet-delivered CBT and CBT face-to-face for severe health anxiety in a randomized controlled trial. A non-inferiority criterion is applied to determine if Internet-delivered CBT is at least as efficacious as its well-established predecessor.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Severe Health Anxiety, Somatic Symptom Disorder, Illness Anxiety Disorder
Keywords
Severe health anxiety, Somatic symptom disorder, Illness anxiety disorder, Cognitive behavioral therapy, Internet, Exposure

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
204 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Conventional CBT
Arm Type
Experimental
Arm Description
Cognitive Behavioural Therapy delivered in a conventional manner
Arm Title
Internet-delivered CBT
Arm Type
Experimental
Arm Description
Cognitive Behavioural Therapy delivered via the Internet
Intervention Type
Behavioral
Intervention Name(s)
CBT, exposure and response prevention (Face-to-face)
Intervention Description
This intervention entails different exercises aimed at exposure to health anxiety stimuli. Treatment is delivered in a conventional manner. Participants are physically meeting with a therapist once a week.
Intervention Type
Behavioral
Intervention Name(s)
CBT, exposure and response prevention (Internet-based)
Intervention Description
This intervention entails different exercises aimed at exposure to health anxiety stimuli. Treatment is delivered via the Internet. Participants are guided by a therapist using an email-like communication system.
Primary Outcome Measure Information:
Title
Health Anxiety Inventory (HAI)
Description
Change in HAI at post-treatment and follow-ups compared to baseline. Analyses will be conducted both within an intention-to-treat (ITT) framework and on a complete case basis. A non-inferiority limit of 0.3 d (effect size) will be used.
Time Frame
baseline, post-treatment (12 weeks), weekly during treatment, 6 month follow-up, 12 month follow-up
Secondary Outcome Measure Information:
Title
Illness Attitude Scale (IAS)
Description
Change in IAS at post-treatment and follow-ups compared to baseline
Time Frame
baseline, post-treatment (12 weeks), 6 month follow-up, 12 month follow-up
Title
Whiteley Index (WI)
Description
Change in WI at post-treatment and follow-ups compared to baseline
Time Frame
baseline, post-treatment (12 weeks), 6 month follow-up, 12 month follow-up
Title
Montgomery-Åsberg Depression Rating Scale - Self report (MADRS-S)
Description
Change in MADRS-S at post-treatment and follow-ups compared to baseline
Time Frame
baseline, post-treatment (12 weeks), 6 month follow-up, 12 month follow-up
Title
Beck Anxiety Inventory (BAI)
Description
Change in BAI at post-treatment and follow-ups compared to baseline
Time Frame
baseline, post-treatment (12 weeks), 6 month follow-up, 12 month follow-up
Title
Anxiety Sensitivity Index (ASI)
Description
Change in ASI at post-treatment and follow-ups compared to baseline
Time Frame
baseline, post-treatment (12 weeks), 6 month follow-up, 12 month follow-up
Title
Sheehan Disability Scale (SDS)
Description
Change in SDS at post-treatment and follow-ups compared to baseline
Time Frame
baseline, post-treatment (12 weeks), 6 month follow-up, 12 month follow-up
Title
Trimbos and institute of medical technology assessment cost questionnaire (TIC-P)
Description
Change in TIC-P at post-treatment and follow-ups compared to baseline
Time Frame
baseline, post-treatment (12 weeks), 6 month follow-up, 12 month follow-up
Title
Euroqol-5D (EQ-5D)
Description
Change in EQ-5D at post-treatment and follow-ups compared to baseline
Time Frame
baseline, post-treatment (12 weeks), 6 month follow-up, 12 month follow-up
Title
Insomnia Severity Index (ISI)
Description
Change in ISI at post-treatment and follow-ups compared to baseline
Time Frame
baseline, post-treatment (12 weeks), 6 month follow-up, 12 month follow-up
Title
Self-rated health 5 (SRH-5)
Description
Change in SRH-5 at post-treatment and follow-ups compared to baseline
Time Frame
baseline, post-treatment (12 weeks), 6 month follow-up, 12 month follow-up
Title
Quality of Life Inventory (QOLI)
Description
Change in QOLI at post-treatment and follow-ups compared to baseline
Time Frame
baseline, post-treatment (12 weeks), 6 month follow-up, 12 month follow-up
Title
Alcohol Use Disorders Identification Test (AUDIT)
Description
Change in AUDIT at post-treatment and follow-ups compared to baseline
Time Frame
baseline, post-treatment (12 weeks), 6 month follow-up, 12 month follow-up
Title
Client Satisfaction Questionnaire (CSQ-8)
Description
For assessing satisfaction with treatment
Time Frame
Post-treatment (12 weeks)
Title
Sickness Questionnaire (SQ)
Description
Change in SQ at post-treatment and follow-ups compared to baseline
Time Frame
baseline, post-treatment (12 weeks), 6 month follow-up, 12 month follow-up
Title
Perceived Vulnerability for Disease (PVD)
Description
Change in PVD at post-treatment and follow-ups compared to baseline
Time Frame
baseline, post-treatment (12 weeks), 6 month follow-up, 12 month follow-up
Title
Disgust Scale-Rev (DS-R)
Description
Change in DS-R at post-treatment and follow-ups compared to baseline
Time Frame
baseline, post-treatment (12 weeks), 6 month follow-up, 12 month follow-up
Title
WHO Disability Assessment Schedule (WHODAS) 2.0, 12-item version
Description
Change in WHODAS at post-treatment and follow-ups compared to baseline
Time Frame
baseline, post-treatment (12 weeks), 6 month follow-up, 12 month follow-up
Other Pre-specified Outcome Measures:
Title
Psychological mediators
Description
Assessment of whether these mediators will precede change in outcome during the treatment. Mediators will be assessed using sub scales of the Health Anxiety Inventory, the Insomnia Severity Index, Self-Rated Health 5 and Acceptance/Flexibility. Common health anxiety behaviors will also be assessed.
Time Frame
week 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
Title
Credibility/Expectancy scale
Description
For assessing treatment credibility and expectancy of improvement
Time Frame
Weeks 2 and 8
Title
Working Alliance Inventory (WAI)
Description
For assessing therapeutic alliance
Time Frame
Weeks 2 and 8

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: A primary diagnosis of severe health anxiety (somatic symptom disorder or illness anxiety disorder) according to the Diagnostic and Statistical Manual of Mental Disorders 5 (DSM-5) Registered citizen of Stockholm county At least 18 years old Exclusion Criteria: Other primary axis-I disorder Substance abuse or addiction during the last 6 months Current or previous episode of psychosis or bipolar disorder Severe major depressive disorder Suicide risk Personality disorder making the treatment procedure very difficult Non-stable psychiatric pharmacotherapy (dosage changed during the last 2 months) and the drug is likely to affect outcome measures Ongoing concurrent psychological treatment for severe health anxiety Having received previous high quality Cognitive Therapy or Cognitive Behavioural Therapy during the recent year Ongoing serious somatic disorder, precluding CBT
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Erik Hedman, Ph.D.
Organizational Affiliation
Karolinska Institutet
Official's Role
Principal Investigator
Facility Information:
Facility Name
Gustavsberg primary care clinic
City
Gustavsberg
State/Province
Stockholm
ZIP/Postal Code
13440
Country
Sweden

12. IPD Sharing Statement

Citations:
PubMed Identifier
22608115
Citation
Hedman E, Andersson E, Lindefors N, Andersson G, Ruck C, Ljotsson B. Cost-effectiveness and long-term effectiveness of internet-based cognitive behaviour therapy for severe health anxiety. Psychol Med. 2013 Feb;43(2):363-74. doi: 10.1017/S0033291712001079. Epub 2012 May 21.
Results Reference
background
PubMed Identifier
25104835
Citation
Hedman E, Axelsson E, Gorling A, Ritzman C, Ronnheden M, El Alaoui S, Andersson E, Lekander M, Ljotsson B. Internet-delivered exposure-based cognitive-behavioural therapy and behavioural stress management for severe health anxiety: randomised controlled trial. Br J Psychiatry. 2014 Oct;205(4):307-14. doi: 10.1192/bjp.bp.113.140913. Epub 2014 Aug 7.
Results Reference
background
PubMed Identifier
24954212
Citation
Olatunji BO, Kauffman BY, Meltzer S, Davis ML, Smits JA, Powers MB. Cognitive-behavioral therapy for hypochondriasis/health anxiety: a meta-analysis of treatment outcome and moderators. Behav Res Ther. 2014 Jul;58:65-74. doi: 10.1016/j.brat.2014.05.002. Epub 2014 May 24.
Results Reference
background
Citation
Furer P, Walker JR. Treatment of Hypochondriasis with Exposure. Journal of Contemporary Psychotherapy 35(3): 251-267, 2005.
Results Reference
background
PubMed Identifier
32401286
Citation
Axelsson E, Andersson E, Ljotsson B, Bjorkander D, Hedman-Lagerlof M, Hedman-Lagerlof E. Effect of Internet vs Face-to-Face Cognitive Behavior Therapy for Health Anxiety: A Randomized Noninferiority Clinical Trial. JAMA Psychiatry. 2020 Sep 1;77(9):915-924. doi: 10.1001/jamapsychiatry.2020.0940.
Results Reference
derived
PubMed Identifier
29222080
Citation
Axelsson E, Lindsater E, Ljotsson B, Andersson E, Hedman-Lagerlof E. The 12-item Self-Report World Health Organization Disability Assessment Schedule (WHODAS) 2.0 Administered Via the Internet to Individuals With Anxiety and Stress Disorders: A Psychometric Investigation Based on Data From Two Clinical Trials. JMIR Ment Health. 2017 Dec 8;4(4):e58. doi: 10.2196/mental.7497.
Results Reference
derived
Links:
URL
http://www.psych.org/File%20Library/Practice/DSM/DSM-5/DSM-5-Somatic-Symptom-Disorder.pdf
Description
On Somatic Symptom Disorder

Learn more about this trial

Cognitive Behavioral Therapy for Health Anxiety: Internet Treatment Versus Face-to-Face Therapy

We'll reach out to this number within 24 hrs